Core Points - The document outlines the written guidelines for securities trading by employees of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, ensuring compliance with relevant laws and regulations [1][2][4] Group 1: General Provisions - The guidelines are established to regulate the trading behavior of employees regarding the company's securities, in accordance with the Company Law and Securities Law of the People's Republic of China [1] - Employees defined in the guidelines include those who may possess undisclosed price-sensitive information due to their positions [1] Group 2: Absolute Prohibitions - Employees are absolutely prohibited from trading company securities if they possess undisclosed price-sensitive information [2][7] - Strict self-discipline is required to avoid insider trading, false trading, market manipulation, and other illegal activities [2][7] Group 3: Other Trading Restrictions - Trading is restricted during specific periods, including 60 days prior to annual performance announcements and 30 days prior to quarterly or semi-annual announcements [2][11] - Directors and senior management are limited to transferring no more than 25% of their holdings annually, with specific conditions for newly acquired shares [14][15] Group 4: Notification and Reporting - Employees must submit a written notification to the board before trading company securities and cannot proceed without written confirmation [3][19] - The company must report any changes in securities holdings within two trading days, including details of the transactions [18] Group 5: Special Circumstances - In special circumstances, such as urgent financial obligations, the board may consider allowing prohibited trades, adhering to regulatory requirements [4][19] - The company must notify the stock exchange of any special circumstances surrounding the trading of securities [19]